Evidence map›Paper›PMID 30101368›Full record

ArticleRheumatology international2019

Is Henoch-Schönlein purpura a susceptibility factor for functional gastrointestinal disorders in children?

Rabia Miray Kisla Ekinci, Sibel Balcı, Okkes Ozgur Mart, Gokhan Tumgor, Sibel Yavuz, Halil Celik, Dilek Dogruel, Derya Ufuk Altintas, Mustafa Yilmaz

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Rabia Miray Kisla EkinciDepartment of Pediatric Rheumatology, Cukurova University Faculty of Medicine, Adana, Turkey. mir_kisla@hotmail.com.ORCID 0000-0001-6234-822X
Sibel BalcıDepartment of Pediatric Rheumatology, Cukurova University Faculty of Medicine, Adana, Turkey.ORCID 0000-0003-0099-313X
Okkes Ozgur MartDepartment of Pediatrics, Cukurova University Faculty of Medicine, Adana, Turkey.
Gokhan TumgorDepartment of Pediatric Gastroenterology, Cukurova University Faculty of Medicine, Adana, Turkey.ORCID 0000-0002-3919-002X
Sibel YavuzDepartment of Pediatric Gastroenterology, Cukurova University Faculty of Medicine, Adana, Turkey.
Halil CelikDepartment of Pediatrics, Cukurova University Faculty of Medicine, Adana, Turkey.
Dilek DogruelDepartment of Pediatric Allergy and Immunology, Cukurova University Faculty of Medicine, Adana, Turkey.ORCID 0000-0003-3972-7277
Derya Ufuk AltintasDepartment of Pediatric Allergy and Immunology, Cukurova University Faculty of Medicine, Adana, Turkey.ORCID 0000-0003-2090-5248
Mustafa YilmazDepartment of Pediatric Rheumatology, Cukurova University Faculty of Medicine, Adana, Turkey.ORCID 0000-0002-6213-8289
Cukurova University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Henoch-Schönlein purpura (HSP), the most common childhood vasculitis is characterized by non-thrombocytopenic palpable purpura, arthritis/arthralgia, abdominal pain and renal involvement. Functional gastrointestinal disorders (FGIDs) are heterogeneous disease spectrum with unclear etiology and include the most common subtypes: functional dyspepsia, irritable bowel syndrome (IBS), functional abdominal pain and functional constipation. Formerly, FGIDs were known as non-organic disorders; however, recent advances revealed that low-grade inflammation may also play a role. We aimed to clarify whether HSP predisposes to FGIDs in pediatric population. Seventy-four children with HSP, diagnosed at least 6 months before the study and 78 healthy controls were enrolled to the study. Patients with red flag signs for organic GI disorders were excluded. Rome IV criteria were utilized for FGIDs diagnosis. We compared the frequencies of FGIDs between HSP patients and healthy subjects. We also examined the parameters including age, abdominal pain, arthralgia, bloody stool, renal involvement and treatment with corticosteroids and laboratory results at HSP diagnosis such as erythrocyte sedimentation rate, C-reactive protein, hemoglobin, leukocytes and platelet counts among patients with and without FGIDs. Overall FGIDs and IBS frequency were 35.1% (n = 26) and 10.8% (n = 8) in HSP patients, 19.2% (n = 15) and 2.6% (n = 2) in healthy controls, respectively. Disease characteristics and laboratory parameters at disease onset were similar between HSP patients with and without FGIDs. Overall FGIDs rate, particularly IBS were statistically higher in HSP patients. We speculate that children with preceding HSP may be predisposed to FGIDs. Since the FGIDs pathogenesis is still remains unclear, further studies are needed to confirm this hypothesis and clarify the etiology. Physicians also should pay attention to FGIDs in HSP patients with ongoing abdominal pain and thus prevent this comorbidity with dietary and psychologic measures.

Indexed as

AdolescentChildChild, PreschoolFemaleGastrointestinal DiseasesHumansIgA VasculitisIrritable Bowel SyndromeMaleRetrospective StudiesAbdominal painChildConstipationFunctional gastrointestinal disorderHenoch–Schönlein purpuraIrritable bowel syndrome

Identifiers

PMID30101368
OpenAlexW2887261802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.